LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
2.070
-0.040 (-1.90%)
Jul 26, 2024, 4:30 PM EDT - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $54.42 million as of July 26, 2024. Its market cap has increased by 0.97% in one year.
Market Cap
54.42M
Enterprise Value
-41.12M
1-Year Change
0.97%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $54.42M, a decrease of -85.69%. That is a compound annual growth rate of -44.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 55.50M | 33.73% |
| Dec 29, 2023 | 41.50M | -54.89% |
| Dec 30, 2022 | 92.00M | -35.12% |
| Dec 31, 2021 | 141.80M | -62.71% |
| Mar 25, 2021 | 380.28M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytosorbents | 55.66M |
| Rallybio | 55.54M |
| Immix Biopharma | 55.47M |
| CollPlant Biotechnologies | 54.98M |
| OKYO Pharma | 54.51M |
| Ocuphire Pharma | 53.40M |
| Fortress Biotech | 53.28M |
| Inotiv | 52.98M |